DOI:
10.1055/s-00000118
Radiologie up2date
LinksClose Window
References
Brandes AA et al.
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
J Clin Oncol 2008;
26: 2192-2197
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.